Vivani Medical, Inc. Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration
Vivani Medical, Inc. (VANI) had Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration of $47.35 million as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Alternative
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration · last filed 2026-03-26
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $47.35M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $47.35M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $47.35M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration |
|---|---|
| 2025-12-31 | $47.35M 10-K · filed 2026-03-26 |
| 2024-12-31 | $47.35M 10-K · filed 2025-03-31 |
| 2023-12-31 | $47.35M 10-K · filed 2024-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B |